![Olivier Samuel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Olivier Samuel
Plus aucun poste en cours
Fortune : 267 954 $ au 31/08/2026
Profil
Olivier Samuel currently works at NewCelX Ltd., as Independent Director.
Mr. Samuel also formerly worked at Kadimastem Ltd., as Director from 2020 to 2023 and NLS Pharmaceutics Ltd., as Independent Director.
Mr. Samuel received his Masters Business Admin degree in 2002 from EM Lyon Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
1,53% | 29/04/2026 | 81 818 ( 1,53% ) | 267 954 $ | 31/08/2026 |
Postes actifs de Olivier Samuel
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Olivier Samuel
| Sociétés | Poste | Fin |
|---|---|---|
| NLS PHARPAR | Directeur/Membre du Conseil | - |
Kadimastem Ltd.
 Kadimastem Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture of regenerative medicines and develops stem cell-based therapeutics | Directeur/Membre du Conseil | - |
Formation de Olivier Samuel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
EM Lyon Business School
 EM Lyon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kadimastem Ltd.
Kadimastem Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture of regenerative medicines and develops stem cell-based therapeutics | Health Technology |
NLS Pharmaceutics Ltd.
 NLS Pharmaceutics Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mental and neurobehavioral disorders | Health Technology |
